These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17939526)

  • 1. [Pharmacotherapy of depression: recent developments].
    Baumann P
    Rev Med Suisse; 2007 Sep; 3(125):2079-80, 2083-4. PubMed ID: 17939526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
    Baghai TC; Volz HP; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):198-222. PubMed ID: 17071541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion: new therapy for depression.
    Feinberg M
    Am Fam Physician; 1990 Jun; 41(6):1787-90. PubMed ID: 2112333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
    Dhir A; Kulkarni SK
    Neurosci Lett; 2008 Nov; 445(1):83-8. PubMed ID: 18778754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apropos of recent antidepressant drugs: some pharmacological comments].
    Montastruc JL; Sénard JM; Lapeyre-Mestre M
    Therapie; 1997; 52(2):143-9. PubMed ID: 9231510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation strategies for treatment-resistant depression.
    Ros S; Agüera L; de la Gándara J; Rojo JE; de Pedro JM
    Acta Psychiatr Scand Suppl; 2005; (428):14-24, 36. PubMed ID: 16307616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological approach to failures of antidepressant treatment].
    Rogue P
    Encephale; 1998; 24(6):575-80. PubMed ID: 9949941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
    Kawai H; Iwadate R; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
    Chronobiol Int; 2019 Sep; 36(9):1194-1207. PubMed ID: 31198056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.
    Sánchez C; Brennum LT; Stórustovu Sí; Kreilgård M; Mørk A
    Pharmacol Biochem Behav; 2007 Mar; 86(3):468-76. PubMed ID: 17303232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentation with atypical antipsychotics for the treatment of patients with a therapy-resistant depression: a review].
    Selis MA; Peeters FP
    Tijdschr Psychiatr; 2008; 50(4):213-22. PubMed ID: 18398801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.